SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-301958
Filing Date
2011-11-08
Accepted
2011-11-08 15:18:01
Documents
9
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ON FORM 10-Q d235118d10q.htm 10-Q 657354
2 CERTIFICATION OF PEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) d235118dex311.htm EX-31.1 5524
3 CERTIFICATION OF PFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) d235118dex312.htm EX-31.2 5678
4 CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 d235118dex321.htm EX-32.1 5034
  Complete submission text file 0001193125-11-301958.txt   2020448

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acrx-20110930.xml EX-101.INS 245495
6 XBRL TAXONOMY EXTENSION SCHEMA acrx-20110930.xsd EX-101.SCH 11900
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20110930_cal.xml EX-101.CAL 31531
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20110930_lab.xml EX-101.LAB 118667
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20110930_pre.xml EX-101.PRE 70669
Mailing Address 575 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 575 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 111187570
SIC: 2834 Pharmaceutical Preparations